Skip to Main Content
Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was unusually long for many on this side of the pond — was relaxing and refreshing, because that predictable routine of meetings, deadlines, and phone calls has, once again, returned. What can you do? The world keeps spinning, no matter how hard we try to slow it down. So, time to grab a cup of stimulation and get cracking. Toward that end, here are some tidbits to get you going. Hope your day is splendid and do keep in touch. …

The U.S. wants Switzerland to extradite Chinese researcher Gongda Xue, who is accused of helping his scientist sister steal secrets worth $550 million from GlaxoSmithKline (GSK), Reuters reports. Gongda Xue, who is fighting extradition, has been labeled a potential flight risk, according to a Swiss Federal Criminal Court verdict, keeping him in custody pending the resolution of the extradition request. Last year, his sister, the Chinese-American scientist Yu Xue, pleaded guilty to pilfering secrets from Glaxo, where she worked until 2016.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.